Scientists who developed a technology for identifying and targeting unique protein receptor ZIP Codes on the cellular surface have found a way to penetrate the outer membrane and deliver engineered particles - called iPhage - to organelles inside the cell.
As part of National Minority Cancer Awareness Week during April 15 to 21, The University of Texas MD Anderson Cancer Center has developed a series of food plate worksheets that focus on nutrition and cancer prevention for African American, Hispanic and Vietnamese audiences.
More than one third of patients with invasive cancer are undertreated for their pain, with minorities twice as likely to not receive analgesics, according to research from The University of Texas MD Anderson Cancer Center.
Ovarian cancer survivors, their friends and families, local businesses, corporate teams and employees of The University of Texas MD Anderson Cancer Center will join forces May 5 at the 15th annual Sprint for Life 5K Run/Walk and Sprint for Sprouts Kids' Run. The approximately 3,000 participants will come together for a common cause: to build awareness of ovarian cancer and raise funds for research.
The University of Texas MD Anderson Cancer Center will offer free head and neck cancer screening exams to the public on Fri., April 27 from 10 a.m. to 3 p.m.
The price of springtime fruits and vegetables seems to increase each year. But when buyers break this expense down to cents, they realize stocking up on these cancer-fighting foods still makes economical sense, say experts from The University of Texas MD Anderson Cancer Center.
‘Conversation’ with former British Prime Minister Tony Blair to support research, patient care.
Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated, researchers reported at the AACR Annual Meeting 2012.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012.
When Dessa Ledet repeatedly experienced pain on the right of her body, she never dreamed she would hear the words "you have cancer" when she woke up from a colonoscopy. In fact, she didn't believe that almost three years after her diagnosis she would run in MD Anderson's seventh annual Sprint for Colorectal Oncology Prevention and Education (SCOPE) Run on Saturday, March 24.
Nancy Hopkins, Ph.D., noted cancer biologist and prominent advocate of equality for women in science, is the 2012 recipient of the Margaret L. Kripke Legend Award for Promotion of Women in Cancer Medicine and Cancer Science presented by The University of Texas MD Anderson Cancer Center.
Identification of a non-traditional pathway for spiriting a cancer-promoting protein into the cell nucleus points to a possible combination therapy for esophageal cancer and indicates a mechanism of resistance for new drugs that attack the Hedgehog pathway.
Polo mallets and palm trees take center stage as Polo Under the Palms returns to Sarasota, Fla., March 24. Proceeds from the second annual competition benefit The University of Texas MD Anderson Cancer Center.
A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease, according to a phase III clinical trial published in the March 1 edition of New England Journal of Medicine.
UT MD Anderson scientists find molecular path of protein associated with hard-to-treat cancers.
Inhibiting telomerase, an enzyme that rescues malignant cells from destruction by extending the protective caps on the ends of chromosomes, kills tumor cells but also triggers resistance pathways that allow cancer to survive and spread, scientists report in the Feb. 17 issue of Cell.
Genomic instability caused by an erosion of the protective caps on chromosomes, followed by activation of an enzyme that reinforces those caps, allows malignant cells to evade destruction and acquire more deadly characteristics, researchers report in an Online Now article at the journal Cell.
MD Anderson research shows promise for patients suffering from chronic pain.
Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.
Economist and health care policy expert Mark B. McClellan, M.D., Ph.D., director of the Engelberg Center for Health Care Reform at Brookings Institution in Washington, D.C., will keynote an address on prevention and health care reform at 8 a.m., Friday, Feb. 17 in The University of Texas MD Anderson Cancer Center’s Hickey Auditorium.
Male fetuses of mothers that are exposed to radiation during early pregnancy may have an increased chance of developing testicular cancer, according to a study in mice at The University of Texas MD Anderson Cancer Center. The article was published today in PLoS ONE.
Sitting for extended periods can raise the chances of developing cancer even for people who exercise regularly, says recent research. In response to these findings, fitness experts at The University of Texas MD Anderson Cancer Center share advice on how to get moving in minutes.
A major building on the campus of The University of Texas MD Anderson Cancer Center today takes on the name of John Mendelsohn, M.D., to honor his leadership of the nation's largest cancer center over 15 years.
New therapy combination prolongs survival in dogs and furthers research for human trials.
A team from The University of Texas MD Anderson Cancer Center is receiving a national award for a research article tackling a question vital to the future of health care with reform regulations looming, competition growing and costs rising.
When SUMO grips STAT5, a protein that activates genes, it blocks the healthy embryonic development of immune B cells and T cells unless its nemesis breaks the hold, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
UT MD Anderson-led team identifies new potential treatment avenue to block an elusive target.
Chronic inflammation combines with DNA methylation, a process that shuts down cancer-fighting genes, to promote development of colorectal cancer, scientists at The University of Texas MD Anderson Cancer Center report today in the advance online publication of the journal Nature Medicine.
Cancer experts from The University of Texas MD Anderson Cancer Center return to West Palm Beach Feb. 11 for the institution’s annual Making Cancer History® seminar. The event, in the Cohen Pavilion of the Raymond F. Kravis Center for the Performing Arts, 701 Okeechobee Blvd., begins at 8:30 a.m. with a breakfast buffet.
Pelvic pain and abnormal bleeding aren’t the only signs of gynecologic cancer. As part of Cervical Health Awareness Month in January, experts at The University of Texas MD Anderson Cancer Center share other symptoms that often are overlooked.
Inflammatory signaling blocks NUMB’s ability to deaden NOTCH1-driven tumor development.
The holidays are here, and The University of Texas MD Anderson Cancer Center Children's Art Project (CAP), offers a line of gifts based on artwork created by pediatric cancer patients. Sale proceeds from each item fund a variety of educational and recreational programs for patients and their families.
Identification of varied survival prospects may guide care for patients whose myelodysplastic syndrome stems from radiation, chemotherapy.
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology.
A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting of the American Society of Hematology.
In an international Phase III randomized study, everolimus, when combined with the hormonal therapy exemestane, has been shown to dramatically improve progression-free survival, according to research from The University of Texas MD Anderson Cancer Center.
Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation (WBI), according to researchers from The University of Texas MD Anderson Cancer Center.
Holiday weight gain doesn’t result from overeating one or two meals. It’s usually from feasting on leftovers for days or even weeks, which can pack on hundreds of extra calories. Adults can avoid holiday weight gain by following advice shared by experts at MD Anderson Cancer Center.
Dallas 'Conversation' With Miles O'Brien to raise funds for cancer research, patient care.
Combination treatment with octreotide shows improved results in tumors associated with carcinoid syndrome
The MD Anderson Cancer Center Board of Visitors (BOV), an appointive board of volunteers dedicated to advancing the initiatives of The University of Texas MD Anderson Cancer Center, welcomes 16 new members in Fiscal Year 2012. These business and community leaders from Texas, Oklahoma, New Mexico and Georgia join more than 200 BOV members who assist in raising funds, awareness and support for MD Anderson.
Academic and government leaders announced today the establishment of a major new research institute at The University of Texas MD Anderson Cancer Center that will blend the best attributes of academic and industrial research to identify and validate new cancer targets, convert such scientific knowledge into new cancer drugs, and advance these novel agents into innovative clinical trials.
About half of male breast cancer patients who take the drug tamoxifen to prevent their disease from returning report side effects such as weight gain and sexual dysfunction, which prompts more than 20 percent of them to discontinue treatment, according to researchers at The University of Texas MD Anderson Cancer Center.
When given alongside radiation therapy for head and neck cancer, acupuncture has shown for the first time to reduce the debilitating side effect of xerostomia, according to new research from The University of Texas MD Anderson Cancer Center and Fudan University Shanghai Cancer Center.
Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.
The survival rates for older women with breast cancer lag behind younger women diagnosed with the disease, indicating that the elder population may be missing out on improvements in treatment and detection, according to new research from The University of Texas MD Anderson Cancer Center.
Adults can avoid holiday weight gain by learning how to choose healthier food portions with the new Thanksgiving serving size infographic, created by experts at The University of Texas MD Anderson Cancer Center.
The embryonic enzyme pyruvate kinase M2 (PKM2) has a well-established role in metabolism and is highly expressed in human cancers. Now, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in advance online publication of the journal Nature that PKM2 has important non-metabolic functions in cancer formation.
A research team led by scientists from The University of Texas MD Anderson Cancer Center have discovered four new "ZIP codes" in their quest to map the vast blood vessel network of the human body.
Two previously unassociated proteins known to be overly active in a variety of cancers bind together to ignite and sustain malignant brain tumors, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports this week in the journal Cancer Cell.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right